Web NewDrugInformation.com

Triprolidine Hcl, Pseudoephedrine Hcl And Codeine Phosphate Drug - Triprolidine Hcl, Pseudoephedrine Hcl And Codeine Phosphate The trade name of the product as shown on the labeling. Dosage - SYRUP; ORAL The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Codeine Phosphate; Pseudoephedrine Hydrochloride; Triprolidine Hydrochloride Multiple ingredients are in alphabetical order. Strength - 10MG/5ML;30MG/5ML;1.25MG/5ML The potency of the active ingredient(s), Codeine Phosphate; Pseudoephedrine Hydrochloride; Triprolidine Hydrochloride. May repeat for multiple part products. Applicant - MORTON GROVE The firm name holding legal responsibility for Triprolidine Hcl, Pseudoephedrine Hcl And Codeine Phosphate. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 088833 The FDA assigned number to Triprolidine Hcl, Pseudoephedrine Hcl And Codeine Phosphate. Format is nnnnnn. Product Number - 001 The FDA assigned number to identify Triprolidine Hcl, Pseudoephedrine Hcl And Codeine Phosphate. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - AA The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - Nov 16, 1984 The date Triprolidine Hcl, Pseudoephedrine Hcl And Codeine Phosphate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - Yes The pioneer or innovator of Triprolidine Hcl, Pseudoephedrine Hcl And Codeine Phosphate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - RX The group or category of approved drugs Triprolidine Hcl, Pseudoephedrine Hcl And Codeine Phosphate is in. Format is RX, OTC, DISCN. Applicant Full Name - Morton Grove Pharmaceuticals Inc The full name of the firm holding legal responsibility for the new application of Triprolidine Hcl, Pseudoephedrine Hcl And Codeine Phosphate. Triprolidine Hcl, Pseudoephedrine Hcl And Codeine Phosphate Promethazine Hcl And Codeine Phosphate 10mg/5ml;6.25mg/5ml Syrup; Oral Promethazine W/ Codeine 10mg/5ml;6.25mg/5ml Syrup; Oral Promethazine W/ Codeine 10mg/5ml;6.25mg/5ml Syrup; Oral Actifed W/ Codeine 10mg/5ml;30mg/5ml;1.25mg/5ml Syrup; Oral Triacin-c 10mg/5ml;30mg/5ml;1.25mg/5ml Syrup; Oral Triprolidine And Pseudoephedrine Hydrochlorides W/ Codeine 10mg/5ml;30mg/5ml;1.25mg/5ml Syrup; Oral Triprolidine Hcl, Pseudoephedrine Hcl And Codeine Phosphate 10mg/5ml;30mg/5ml;1.25mg/5ml Syrup; Oral Pherazine W/ Codeine 10mg/5ml;6.25mg/5ml Syrup; Oral Prometh W/ Codeine 10mg/5ml;6.25mg/5ml Syrup; Oral Promethazine Hcl And Codeine Phosphate 10mg/5ml;6.25mg/5ml Syrup; Oral NewDrugInformation